0.05 ML bevacizumab-vikg 25 MG/ML Injection [Lytenava]

RxNorm concept 2749117, branded drug (sbd). Prescribable name: LYTENAVA 1.25 MG in 0.05 ML Injection.

RxCUI: 2749117
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2749117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

bevacizumab 253337

Other names

Lytenava 1.25 MG per 0.05 ML Injection

Related concepts

bevacizumab-vikg 25 MG/ML (SCDC, consists of)
bevacizumab-vikg 25 MG/ML [Lytenava] (SBDC, consists of)
Injection (DF, has dose form)
Lytenava (BN, has ingredient)
0.05 ML bevacizumab-vikg 25 MG/ML Injection (SCD, tradename of)

Linked data

NDCs

82491002510

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2749117 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2749117 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2749117. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.